3X5-18962-17196
4 vaccinations
2 coded responses
44 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 660 / KS
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
LJM-33625-84080
Child or adolescent in my care · Female · 2022-06-25
C63-56597-73110
Child or adolescent in my care · Male · 2022-07-15
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Pfizer-BioNTech
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-19
- 2021-02-20
-
2021-02-21
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-10
-
2021-03-12
Dose 2 — Pfizer-BioNTech
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-19
- 2021-03-28
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-06-11
- 2021-09-10
-
2021-09-24
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-01
Health check-in — day 7, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-08
- 2021-10-17
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-12-24
- 2022-03-25
-
2022-09-23
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-24
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-30
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-05
-
2022-12-23
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-23
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-12 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-23 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-23 | Successful 2022-12-27 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Release 12 — 3 months, dose 4
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release